6533b7ddfe1ef96bd12740e3

RESEARCH PRODUCT

New Highlights of Resveratrol: A Review of Properties against Ocular Diseases

Virginie AiresVirginie AiresJianbo XiaoJianbo XiaoJianbo XiaoDominique DelmasDominique DelmasClarisse CornebiseClarisse CornebiseFlavie CourtautFlavie Courtaut

subject

0301 basic medicinegenetic structuresEye DiseasesReviewDiseaseresveratrolAMDResveratrolBioinformaticsAntioxidantsEpigenesis Geneticlcsh:Chemistryangiogenesischemistry.chemical_compoundDrug Delivery Systems0302 clinical medicineSirtuin 1Gene Regulatory Networkslcsh:QH301-705.5Spectroscopy3309.20 Propiedades de Los AlimentosClinical Trials as TopicGeneral MedicineDiabetic retinopathyComputer Science Applicationsdiabetic retinopathycataract3201.09 OftalmologíanutraceuticalCatalysisInorganic Chemistry03 medical and health sciences2302 BioquímicamedicineHumansPhysical and Theoretical ChemistryMolecular BiologypolyphenolsMolecular signalingbusiness.industryocular diseasesOrganic ChemistryeyesMacular degenerationmedicine.diseaseeye diseasesClinical trial030104 developmental biologylcsh:Biology (General)lcsh:QD1-999Gene Expression Regulationchemistry030221 ophthalmology & optometryReactive Oxygen Speciesbusiness

description

Eye diseases are currently a major public health concern due to the growing number of cases resulting from both an aging of populations and exogenous factors linked to our lifestyles. Thus, many treatments including surgical pharmacological approaches have emerged, and special attention has been paid to prevention, where diet plays a preponderant role. Recently, potential antioxidants such as resveratrol have received much attention as potential tools against various ocular diseases. In this review, we focus on the mechanisms of resveratrol against ocular diseases, in particular age-related macular degeneration, glaucoma, cataract, diabetic retinopathy, and vitreoretinopathy. We analyze, in relation to the different steps of each disease, the resveratrol properties at multiple levels, such as cellular and molecular signaling as well as physiological effects. We show and discuss the relationship to reactive oxygen species, the regulation of inflammatory process, and how resveratrol can prevent ocular diseases through a potential epigenetic action by the activation of sirtuin-1. Lastly, various new forms of resveratrol delivery are emerging at the same time as some clinical trials are raising more questions about the future of resveratrol as a potential tool for prevention or in therapeutic strategies against ocular diseases. More preclinical studies are required to provide further insights into RSV’s potential adjuvant activity. Agence Nationale de la Recherche, France | Ref. ANR-11-LABX-0021

https://doi.org/10.3390/ijms22031295